购物车
- 全部删除
- 您的购物车当前为空
Taurohyodeoxycholic acid(牛磺酸去氧胆酸)是一种胆汁酸,在调节肝脏炎症微环境方面发挥着关键作用。THDCA可以减少TNF-α和IL-6的表达并抑制肝细胞癌(HCC)的发展。能够结合黄芪多糖抑制非酒精性脂肪性肝病,调节胆汁酸代谢:通过上调CYP7B1和下调CYP7A1,降低肝脏中CD36的表达,减少肝脏脂质积累。
Taurohyodeoxycholic acid(牛磺酸去氧胆酸)是一种胆汁酸,在调节肝脏炎症微环境方面发挥着关键作用。THDCA可以减少TNF-α和IL-6的表达并抑制肝细胞癌(HCC)的发展。能够结合黄芪多糖抑制非酒精性脂肪性肝病,调节胆汁酸代谢:通过上调CYP7B1和下调CYP7A1,降低肝脏中CD36的表达,减少肝脏脂质积累。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 412 | 现货 | |
5 mg | ¥ 993 | 现货 | |
10 mg | ¥ 1,460 | 现货 | |
25 mg | ¥ 2,470 | 现货 | |
50 mg | ¥ 3,680 | 现货 | |
100 mg | ¥ 5,880 | 现货 | |
200 mg | ¥ 7,950 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | Taurohyodeoxycholic acid (THDCA) is a bile acid that plays a key role in regulating the hepatic inflammatory microenvironment.THDCA reduces the expression of TNF-α and IL-6 and inhibits the development of hepatocellular carcinoma (HCC). It is able to inhibit non-alcoholic fatty liver disease and regulate bile acid metabolism in combination with astragalus polysaccharides: it reduces CD36 expression in the liver and decreases hepatic lipid accumulation by up-regulating CYP7B1 and down-regulating CYP7A1. |
别名 | 牛磺猪去氧胆酸, Taurohyodeoxycholic Acid MaxSpec® Standard |
分子量 | 499.7 |
分子式 | C26H45NO6S |
CAS No. | 2958-04-5 |
Smiles | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@]([C@@H](CCC(NCCS(=O)(=O)O)=O)C)(CC4)[H])[H])(C[C@H](O)[C@@]1(C[C@H](O)CC2)[H])[H])[H] |
密度 | 1.216 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容